Cargando…
Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis
Exacerbations of chronic bronchitis (AECB) are a major cause of morbidity and mortality in patients with chronic obstructive pulmonary disease (COPD), and their impact on public health is increasing. The new fluoroquinolones have an excellent spectrum providing cover for the most important respirato...
Autores principales: | Blasi, Francesco, Aliberti, Stefano, Tarsia, Paolo, Santus, PierAchille, Centanni, Stefano, Allegra, Luigi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692114/ https://www.ncbi.nlm.nih.gov/pubmed/18044063 |
Ejemplares similares
-
How air pollution influences clinical management of respiratory diseases. A case-crossover study in Milan
por: Santus, Pierachille, et al.
Publicado: (2012) -
The biology of pulmonary exacerbations in bronchiectasis
por: Amati, Francesco, et al.
Publicado: (2019) -
Cefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis: serum inflammatory biomarkers, clinical efficacy, and microbiological eradication
por: Blasi, Francesco, et al.
Publicado: (2013) -
Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Α Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice—The “AIOLOS” Study
por: Gourgoulianis, Konstantinos, et al.
Publicado: (2021) -
Acute Improvements of Oxygenation with Cpap and Clinical Outcomes in Severe COVID-19 Pneumonia: A Multicenter, Retrospective Study
por: Pini, Stefano, et al.
Publicado: (2022)